We are live on !
Find out more
St. Denis J. Villere & Co Portfolio holdings
AUM
$838M
Turnover
17.05%
1-Year Est. Return
14.24%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+14.24%
3 Year Est. Return
+32.61%
5 Year Est. Return
+35.15%
10 Year Est. Return
+260.87%
AUM
$838M
AUM Growth
-$69.2M
(-7.6%)
Cap. Flow
-$123M
Cap. Flow % of AUM
Cap. Flow %
-14.72%
Top 10 Holdings %
Top 10 Hldgs %
38.24%
Holding
88
New
12
Increased
4
Reduced
45
Closed
3
Avg Time Held
4.6
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$8.18M |
| 2 |
Schwab US Large-Cap Value ETF
SCHV
|
+$4.43M |
| 3 |
Schwab US Mid-Cap ETF
SCHM
|
+$3.04M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$2.31M |
| 5 |
Schwab International Dividend Equity ETF
SCHY
|
+$1.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caesars Entertainment
CZR
|
+$22.8M |
| 2 |
Microchip Technology
MCHP
|
+$12.8M |
| 3 |
ON Semiconductor
ON
|
+$11.1M |
| 4 |
Atlas Energy Solutions
AESI
|
+$8.29M |
| 5 |
Ligand Pharmaceuticals
LGND
|
+$7.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.12% |
| 2 | Financials | 16.92% |
| 3 | Technology | 14.44% |
| 4 | Industrials | 9.25% |
| 5 | Energy | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Ligand Pharmaceuticals
LGND
$6.14B
| $49.2M | 5.87% |
155,506
-33,368
| -18% | -$7.86M |
2020 Q1
25 quarters
|
|
2
JPMorgan Chase
JPM
$894B
| $38.3M | 4.57% |
116,855
-11,274
| -9% | -$3.5M |
2013 Q2
52 quarters
|
|
3
Visa
V
$778B
| $34.3M | 4.09% |
99,938
-15,634
| -14% | -$5.02M |
2013 Q2
52 quarters
|
|
4
Amazon
AMZN
$2.7T
| $32.6M | 3.89% |
136,855
-19,938
| -13% | -$5M |
2020 Q1
25 quarters
|
|
5
Chevron
CVX
$445B
| $29.8M | 3.56% |
179,914
-15,175
| -8% | -$2.82M |
2013 Q2
52 quarters
|
|
6
Apple
AAPL
$5.08T
| $28.3M | 3.38% |
97,884
-7,174
| -7% | -$2.05M |
2013 Q2
52 quarters
|
|
7
Palomar
PLMR
$3.8B
| $27.3M | 3.26% |
216,269
-30,274
| -12% | -$3.56M |
2020 Q4
22 quarters
|
|
8
Johnson & Johnson
JNJ
$645B
| $27.1M | 3.24% |
106,775
-14,522
| -12% | -$3.38M |
2013 Q2
52 quarters
|
|
9
Lineage Inc
LINE
$7.99B
| $26.7M | 3.19% |
618,495
-89,430
| -13% | -$3.52M |
2024 Q3
7 quarters
|
|
10
Freeport-McMoran
FCX
$92.8B
| $26.7M | 3.19% |
424,397
-50,089
| -11% | -$3.22M |
2021 Q3
19 quarters
|
|
11
Lockheed Martin
LMT
$136B
| $25.5M | 3.04% |
49,956
-4,414
| -8% | -$2.39M |
2015 Q1
45 quarters
|
|
|
12
Atlas Energy Solutions
AESI
$1.08B
| $22.4M | 2.68% |
1,349,299
-506,788
| -27% | -$8.29M |
2023 Q3
11 quarters
|
|
|
13
ON Semiconductor
ON
$28.5B
| $22.3M | 2.66% |
235,874
-108,580
| -32% | -$11.1M |
2019 Q2
28 quarters
|
|
14
First Interstate BancSystem
FIBK
$3.51B
| $21.9M | 2.61% |
567,701
-59,330
| -9% | -$2.1M |
2024 Q2
8 quarters
|
|
15
Pool Corp
POOL
$7.17B
| $20.9M | 2.49% |
97,043
-19,650
| -17% | -$3.92M |
2013 Q2
52 quarters
|
|
16
Bank of America Series L
BAC.PRL
$3.6B
| $20.7M | 2.47% |
16,522
-2,090
| -11% | -$2.55M |
2021 Q4
18 quarters
|
|
17
On Holding
ONON
$11.4B
| $20.7M | 2.47% |
583,236
-32,551
| -5% | -$1.19M |
2022 Q3
15 quarters
|
|
18
Steris
STE
$22.6B
| $20.6M | 2.46% |
97,996
-10,767
| -10% | -$2.31M |
2018 Q4
30 quarters
|
|
19
Stryker
SYK
$118B
| $20.3M | 2.42% |
64,469
-10,795
| -14% | -$3.4M |
2020 Q2
24 quarters
|
|
20
Abbott
ABT
$177B
| $18.9M | 2.26% |
208,824
-21,638
| -9% | -$1.97M |
2016 Q2
40 quarters
|
|
|
21
Microchip Technology
MCHP
$40.5B
| $17.9M | 2.14% |
196,535
-142,982
| -42% | -$12.8M |
2013 Q2
52 quarters
|
|
22
Idexx Laboratories
IDXX
$44.6B
| $17.8M | 2.12% |
33,743
-4,993
| -13% | -$2.8M |
2022 Q2
16 quarters
|
|
23
Colgate-Palmolive
CL
$77.6B
| $17.7M | 2.11% |
193,222
-34,658
| -15% | -$3.03M |
2013 Q2
52 quarters
|
|
24
Roper Technologies
ROP
$43.1B
| $17.6M | 2.1% |
51,933
-6,084
| -10% | -$2.07M |
2018 Q4
30 quarters
|
|
25
Progressive
PGR
$133B
| $17.4M | 2.08% |
79,788
-7,840
| -9% | -$1.58M |
2018 Q1
33 quarters
|
|
Similar funds
St. Denis J. Villere & Co's Q2 2026 Portfolio in Review
As of Q2 2026, St. Denis J. Villere & Co held 88 positions worth $838M, down 7.6% from $907M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
St. Denis J. Villere & Co withdrew a net $123M in Q2 2026, closing 3 positions and reducing 45 holdings. Its most notable exit was Schwab International Equity ETF, an estimated $487K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
Against the trend, St. Denis J. Villere & Co opened a new position in Schwab US Large-Cap Growth ETF worth $8.36M.
- St. Denis J. Villere & Co's largest Q2 2026 buy was Schwab US Large-Cap Growth ETF: 246,998 shares worth $8.36M.
- St. Denis J. Villere & Co added most to Remitly in Q2 2026, an estimated $205K increase.
- St. Denis J. Villere & Co's biggest Q2 2026 reduction was Caesars Entertainment, cutting an estimated $22.8M.
- St. Denis J. Villere & Co fully exited Schwab International Equity ETF in Q2 2026, selling an estimated $487K.
- St. Denis J. Villere & Co's ten largest holdings make up 38% of its $838M portfolio in Q2 2026.
- St. Denis J. Villere & Co opened 12 new positions and closed 3 in Q2 2026.
- St. Denis J. Villere & Co's portfolio value fell 7.6% quarter-over-quarter to $838M.
Based on St. Denis J. Villere & Co's 13F filing for Q2 2026, filed 7 Aug 2026.